NimBio

Company Overview

Snapshot

Founded in January 2019 by Tal Atarot, NimBio operates with 1–10 employees. The company has raised a total of $1.37 million across three funding rounds from two investors. In January 2025, NimBio secured follow-on funding from eHealth Ventures.

Business overview

NimBio develops non-invasive, AI-powered technology to detect early signs of inflammation in real time, aiming to prevent flares in chronic inflammatory diseases. Its core product, the Inflammometer™, is designed to integrate into everyday devices like smartwatches or fitness bands, passively collecting data to reduce hospitalizations and complications through timely treatment optimization. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare, Patient Remote Monitoring, and Medical Decision Support, serving global markets.

Strategic signal

In November 2024, NimBio was recognized as one of Europe's thirty most promising life science and healthtech startups by EIT Health Catapult. This selection validates the company's innovative approach to chronic inflammatory disease management and signals strong potential for market impact and investor interest within the European healthcare ecosystem.

Company Intelligence Q&A

What is NimBio's core technology?

NimBio's core technology is the Inflammometer™, a non-invasive, AI-powered solution designed to passively collect real-time data for the early detection of flares in chronic inflammatory diseases. This technology aims to reduce hospitalizations and complications by enabling timely treatment optimization.

When was NimBio founded and by whom?

NimBio was founded in January 2019 by Tal Atarot.

What was a significant recent achievement for NimBio?

In November 2024, NimBio was recognized as one of the thirty most promising life science and healthtech startups in Europe by EIT Health Catapult.

Which investors have participated in NimBio's funding rounds?

NimBio has received funding from eHealth Ventures and the Israel Innovation Authority. eHealth Ventures provided follow-on funding in January 2025 and led a round in November 2022.

What is the total capital raised by NimBio?

NimBio has raised a total of $1.37 million across three funding rounds.